Incidence and clinical significances of human T-cell lymphotropic virus type I-associated myelopathy with T2 hyperintensity on spinal magnetic resonance images

Internal Medicine

Volumn 47, Issue 21, 2008, Pages 1881-1886

  Yukitake, Motohiro ^a   Takase, Yukinori ^b   Nanri, Yusuke ^a   Kosugi, Masafumi ^a   Eriguchi, Makoto ^a   Yakushiji, Yusuke ^a   Okada, Ryuichiro ^a   Mizuta, Haruo ^a   Kuroda, Yasuo ^a  

^a SAGA UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

HTLV I associated myelopathy; Magnetic response imaging; Myelitis; Spinal cord atrophy; T2 hyperintensity; Tropical spastic paraparesis

Indexed keywords

ALPHA INTERFERON; GADOLINIUM; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BRAIN DYSFUNCTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DATA ANALYSIS; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMAGE ANALYSIS; INCIDENCE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARAPLEGIA; SPASTIC PARAPLEGIA; SPINAL CORD ATROPHY; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SPINAL CORD; SPINAL CORD DISEASES;

EID: 56349099637     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1284     Document Type: Article

References (26)

1. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells. Ann Neurol 21: 117-122, 1987.
2. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407-410, 1985.
3. Kermode AG, Rudge P, Thompson AJ, du Boulay EP, McDonald WI. MRI of thoracic cord in tropical spastic paraparesis [letter]. J Neurol Neurosurg Psychiatry 53: 1110-1111, 1990.
4. Melo A, Moura L, Rios S, Machado M, Costa G. Magnetic resonance imaging in HTLV-I associated myelopathy. Arq Neuropsiquiatr 51: 329-332, 1993.
5. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Human Retrovirology HTLV. Blattner W. Ed. Raven Press, New York, 1990: 191-197.
6. Ferraz AC, Gabbai AA, Abdala N, Nogueira RG. Magnetic resonance in HTLV-I associated myelopathy. Leukoencephalopathy and spinal cord atrophy. Arq Neuropsiquiatr 55: 728-736, 1997 (in Portuguese).
7. Bagnato F, Butman JA, Mora CA, et al. Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis. J Neurovirol 11: 525-534, 2005.
8. Alcindor F, Valderrama R, Canavaggio M, et al. Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies. Neuroradiology 35: 69-74, 1992.
9. Shakudo M, Inoue Y, Tsutada T. HTLV-I-associated myelopathy: acute progression and atypical MRI findings. AJNR 20: 1417-1421, 1999.
10. Yanagihara C, Nakaji K, Nishimura Y. A case of HTLV-I associated myelopathy with abnormal MRI lesions in the spinal cord. Rinshou Shinkeigaku (Clin Neurol) 40: 254-258, 2000 (in Japanese, Abstract in English).
11. Watanabe M, Yamashita T, Hara A, et al. High signal in the spinal cord on T2-weighted images in rapidly progressive tropical spastic paraparesis. Neuroradiology 43: 231-233, 2001.
12. Tajima Y, Kishimoto R, Sudoh K, Miyazaki Y, Kikuchi S, Tashiro K. Spinal magnetic resonance image alterations in human T-lymphotropic virus type I-associated myelopathy patients before and after immunomodulating treatments. J Neurol 250: 750-753, 2003.
13. Umehara F, Tokunaga N, Hokezu Y, et al. Relapsing cervical cord lesions on MRI in patients with HTLV-I-associated myelopathy. Neurology 66: 289, 2006.
14. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452, 1983.
15. Godoy AJ, Kira J, Hasuo K, Goto I. Characterization of cerebral white matter lesions of HTLV-I associated myelopathy/tropical spastic paraparesis in comparison with multiple sclerosis and collagen-vasculitis: a semiquantitative MRI study. J Neurol Sci 133: 102-111, 1995.
16. Howard AK, Li DK, Oger J. MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives. Can J Neurol Sci 30: 41-48, 2003.
17. Kuroda Y, Matsui M, Yukitake M, et al. Assessment of MRI criteria for MS in Japanese MS and HAM/TSP. Neurology 45: 30-33, 1995.
18. Lycklama G, Thompson A, Filippi M, et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol 9: 555-562, 2003.
19. Lin X, Tench CR, Evangelou N, Jaspan T, Constantinescu CS. Measurement of spinal cord atrophy in multiple sclerosis. J Neuroimaging 14 (Suppl 3): 20S-26S, 2004.
20. Bakshi R, Dandamudi VS, Neema M, De C, Bermel RA. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis. J Neuroimaging 15 (Suppl 4): 30S-45S, 2005.
21. Izumo S, Goto I, Itoyama Y, et al. Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology 46: 1016-1021, 1996.
22. Yamasaki K, Kira J, Koyanagi Y, et al. Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study. J Neurol Sci 147: 135-144, 1997.
23. Nakagawa M, Izumo S, Ijichi S, et al. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1: 50-61, 1995.
24. Kuroda Y, Fujiyama F, Nagumo F. Analysis of factors of relevance to rapid clinical progression in HTLV-I-associated myelopathy. J Neurol Sci 105: 61-66, 1991.
25. Umehara F, Nagatomo S, Yoshishige K, et al. Chronic progressive cervical myelopathy with HTLV-I infection: Variant form of HAM/TSP? Neurology 63: 1276-1280, 2004.
26. Umehara F, Nose H, Saito M, et al. Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy. J Neurovirol 3: 260-267, 2007.